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About the electronic Persistent Pain Outcomes 
Collaboration (ePPOC)  
 
ePPOC is a program which aims to help improve services and outcomes for patients experiencing chronic 
pain through benchmarking of care and treatment. ePPOC is an initiative of the Faculty of Pain Medicine, 
and has been further developed in recent years by the Faculty and the wider pain sector. 
ePPOC involves the collection of a standard set of data items and assessment tools by specialist pain 
services throughout Australia and New Zealand to measure outcomes for their patients as a result of 
treatment. This information is being used to develop an Australasian benchmarking system for the pain 
sector, facilitating better outcomes and best practice interventions for patients experiencing chronic pain. 
The information will also enable development of a coordinated approach to research into the management 
of pain in Australasia. 
Participation in ePPOC is voluntary and aims to assist pain management service providers to improve 
practice. epiCentre (the software purpose-built for ePPOC) helps to achieve this by: 
 providing clinicians with an approach to systematically assess individual patient experience 
 defining a common clinical language to streamline communication between pain management 
providers 
 facilitating the routine collection of Australasian pain management data to drive quality 
improvement through reporting and benchmarking.  
The ePPOC team is located within the Australian Health Services Research Institute at the University of 
Wollongong. If you would like more information about ePPOC please visit our website at 
https://ahsri.uow.edu.au/eppoc, email us at eppoc@uow.edu.au or phone (02) 4221 5058.
 
       
‘All services’ represents data collected by 69 services 
 
 
 
 
 
 
 
 
 
 
 
Executive Summary for Enterprise One Pain Management Service 
2019 Mid Year Report — 1 July 2018 to 30 June 2019 
Demographic information  Service provision 
       
 Enterprise 
One 
All  
services 
  Enterprise 
One 
All  
services 
Active patients 680 32252  Episodes started 495 22577 
Gender (female) 61.8% 57.5% 
 Days from referral to episode start 
(median) 
 83.0  60.0 
Average age (years) 52.5 50.3  Treatment pathway type (%)   
Interpreter required 1.7% 4.0%   Group program  14.0  23.2 
Communication assistance reqd 8.8% 7.8%   Individual  14.9  67.3 
Outside normal BMI range 77.2% 74.1%   Concurrent  71.1   8.9 
Area of highest disadvantage 13.0% 20.9%   One-off   0.0   0.6 
Aboriginal and/or  
Torres Strait Islander  
7.8% 4.2%  Episodes ended 271 14645 
Patient profile at referral 
Enterprise One received 494 completed referral questionnaires in this period 
       
Assessment tool 
scores 
Enterprise 
One 
All 
services 
  Enterprise 
One 
All 
services 
Pain Severity 6.2 6.2  Average number of pain sites  4.4  4.1 
Pain Interference 6.7 6.9  Average number of comorbidities  2.5  2.1 
Depression 17.6 18.3  % of patients using opioids > 2 days/week  55.8  57.0 
Anxiety 12.6 12.6  Average oMEDD (mg)  79.7  60.2 
Stress 18.8 19.8  Average number of drug groups used   2.4   2.2 
Pain Catastrophising 26.4 27.2  % of patients unemployed due to pain 40.2 38.6 
Pain Self-Efficacy 24.0 21.7  % of patients experiencing pain >5 years 54.4 40.4 
 Ext. severe  Severe  Moderate/High (PCS only)  Mild  Normal/Minimal 
Patient outcomes 
       
Number/percent of outcomes 
compared to previous period 
Enterprise One All services 
This period Last report % increase This period Last report % increase 
Pathway outcomes 122          110     10.9 5834         5754      1.4 
Episode outcomes 112          106      5.7 5572         5408      3.0 
Post episode  39           43     -9.3 2454         2563     -4.3 
       
Number/percent of outcomes  
collected 
Enterprise One All services 
Number of 
outcomes 
Number 
ended 
% with 
outcomes 
Number of 
outcomes 
Number 
ended 
% with 
outcomes 
Pathway  122          179     68.2 5834        11970     48.7 
Episode  112          271     41.3 5572        14645     38.0 
Post episode  39          133     29.3 2454         9015     27.2 
 
       
‘All services’ represents data collected by 69 services 
 
 
Benchmark (BM) Description BM 
BM 
met? 
Your 
service  
All 
services  
Services 
met BM  
      
1. Average pain  
Patients with moderate or severe average pain at referral have made 
clinically significant improvement at episode end 
40% No 29.2% 33.7% 15 
2. Pain interference  
Patients with moderate or severe pain interference at referral have made 
clinically significant improvement at episode end 
70% No 68.0% 63.4% 9 
3. Depression  
Patients with moderate, severe or extremely severe depression at referral 
have made clinically significant improvement at episode end 
70% No 50.7% 59.7% 5 
4. Anxiety 
Patients with moderate, severe or extremely severe anxiety at referral 
have made clinically significant improvement at episode end 
50% No 42.6% 45.9% 17 
5. Stress  
Patients with moderate, severe or extremely severe stress at referral have 
made clinically significant improvement at episode end 
60% No 57.6% 61.8% 27 
6. Pain catastrophising  
Patients with high or severe pain catastrophising at referral have made 
clinically significant improvement at episode end 
70% No 60.8% 58.8% 8 
7. Pain self-efficacy  
Patients with impaired self-efficacy (moderate or severe) at referral have 
made clinically significant improvement at episode end 
60% No 54.7% 51.9% 16 
8. Opioid use 
Patients taking opioids at referral who report a reduction in their oMEDD 
of at least 50% at episode end 
50% Yes 55.0% 47.6% 18 
9. Opioid use (high dose) 
Patients on 40mg or more oMEDD at referral who report a reduction of at 
least 50% at episode end 
60% No 54.5% 43.7% 4 
10. Waiting time 
Episodes start within 92 days of the referral being received 
80% No 57.2% 65.3% 26 
†oMEDD= oral morphine equivalent daily dose 
‘na’ is shown for the benchmarks and indicators where less than 10 referral to episode end outcomes are reported 
Benchmark and Indicator Summary for Enterprise One Pain Management Service 
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Introduction 
ePPOC aims to assist services to improve the quality of the pain management they provide through the 
analysis and benchmarking of patient outcomes. In this report, data submitted for patients active* during the 
period 1 July 2018 to 30 June 2019 are summarised to enable participating services to assess their 
performance and compare this with outcomes achieved by other services.  
This report is divided into three sections: 
 Section 1 provides a summary of the data and outcomes included in this report 
 Section 2 presents detailed analyses of the outcome measures and benchmark comparisons 
 Section 3 provides descriptive analysis at each of the patient, episode and pathway data levels. 
The figures reflect all pain management services that submitted data during the reporting period. Data from 
69 adult services are included in this report. 
In each of the sections, data and analyses for Enterprise One Pain Management Service are presented 
alongside those for All Services for comparative purposes. This process of reporting and benchmarking 
against other services provides opportunities to understand the services that are provided to patients, the 
outcomes patients experience and to demonstrate and address variations in practice and outcomes. 
Data in the tables in this report are determined by a data scoping method. This defines what data are 
included and can vary from table to table. Patients in each of the time points are not necessarily the same. 
More information about data scoping can be found in Appendix A.  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
*The completion of a questionnaire or the occurrence of a service event determines whether a patient, episode or pathway is 
‘active’. 
  
 
       
Patient Outcomes in Pain Management, 2019 Mid Year Report 
2 
What’s new in this report?  
There are three new types data and information displayed in this report: 
 Section 2: Time series graphs 
 Section 3: Socioeconomic disadvantage quintile graph (based on patient area of residence)  
 Section 3: Body Mass Index (BMI) table  
 
Time series graphs 
The new time series graphs show change in performance on each of the benchmarks over time (i.e. the last 5 
years). The time series graphs are throughout Section 2. An example follows, with tips for interpreting the 
graphs.  
 
 Results are reported at 12 month intervals over a 5 
year period with either Mid Year or Annual results, 
corresponding to the current report 
 Results are based on the current benchmark/indicator 
definition 
 Results may not precisely match previously reported 
results due to a change in definition and/or updated 
data 
 The darker line indicates the result for your service 
 The lighter line indicates the average for All services 
 The red line indicates the threshold at which the 
benchmark is currently set 
 If there is no dot for your service for any period, this 
indicates that your service reported less than 10 
outcomes 
 When numbers are low, these graphs should be 
interpreted with caution due to increased volatility 
 
Socioeconomic disadvantage figure 
Figure 59 shows the relative socioeconomic disadvantage of your patient population based on residential 
address at referral. The information uses the Socio-Economic Index for Areas – Index of Relative 
Disadvantage, and the New Zealand Index of Relative Socioeconomic Deprivation. These indices group 
residential area into five disadvantage quintiles (from least to most) such that across the national Australian 
and New Zealand populations, 20% of people live in each disadvantage quintile. It’s important to note that 
the level of disadvantage relates to the area the person lives in rather than the person.  
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Figure 59 compares the proportion of your patients who live in each disadvantage quintile to:  
 the population of all people seeking pain management in Australasia (All services) 
 the expected distribution of disadvantage (Australasian expected percentage)  
 
 
Body Mass Index table 
Table 36 shows Body Mass Index (BMI) information for your patients compared to All services. This uses data 
collected at referral and is presented as the proportion of people who are underweight, normal weight, 
overweight and obese.  
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Section 1 — Summary of data and outcomes included 
in this report 
1.1 Data summary 
Sixty nine services provided information on 32252 patients. The services providing data for this report are 
shown in Appendix B. 
Table 1 includes data based on activity during the reporting period. 
Table 1  Number and percentage of patients, episodes, pathways and questionnaires 
 Enterprise One All Services 
Number of active patients 680 32252 
Number of episodes 517 25563 
Number of pathways 242 16379 
Number of questionnaires returned 839 35511 
Response rate to questionnaires (%)† 96.6 78.0 
†  The number of questionnaires completed as a percentage of the number sent 
The relationship between the different levels of information collected under ePPOC (patient, episode, 
pathway, service event and questionnaires) is shown in Appendix C. 
Table 2 shows the number and type of questionnaires received by Enterprise One. 
Table 2  Number of questionnaires completed in the reporting period by questionnaire type 
 Enterprise One All Services 
Referral 494 21394 
Pathway start 79 2632 
Group program start (concurrent pathways only) 69 154 
Pathway review 2 882 
Group program end (concurrent pathways only) 70 156 
Pathway end 62 5846 
Post episode  39 2370 
Ad hoc 24 2077 
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1.2 Patient reported outcome measure summary at referral 
Table 3 shows patients’ average scores across the assessment tools for referral questionnaires received in 
the reporting period. Non-valid scales and subscales have been excluded from this table.   
Table 3  Average outcome measure scores at referral 
Outcome measure 
Enterprise One All Services 
n=494 n=21394 
BPI   
Severity§ 6.2 6.2 
Interference 6.7 6.9 
DASS   
Depression 17.6 18.3 
Anxiety 12.6 12.6 
Stress 18.8 19.8 
PCS total 26.4 27.2 
PSEQ* total 24.0 21.7 
§ The severity score is an average of the four severity items 
* Note: For the PSEQ assessment tool, higher scores reflect greater confidence in ability to perform activities despite the pain. 
See Supplementary Data 1 for more information on the volume and proportion of missing responses and 
validity. See Supplementary Data 2 for more information on changes in outcome scores for patients who 
have completed both a referral and pathway start questionnaire. Further information on assessment tools, 
subscales and definition of clinically significant improvement can be found in Appendix D.  
Table 4 shows medication use at referral. The oMEDD calculations includes only those patients taking opioids 
at referral. 
Table 4  Medication use at referral 
Medication use Enterprise One All Services 
Percent using opioids >2 days/week  
(n=346, 14529)* 
55.8 57.0 
oMEDD (mg) ^  (n=182, 8578)*  
Average  79.7 60.2 
Median 40.0 38.0 
Ave number of major drug groups (n=368, 16037)* 2.4 2.2 
Percent using (n=368,16036)*   
Opioids  62.2 57.3 
Paracetamol 55.7 48.8 
NSAIDs  31.3 33.1 
Antidepressants  37.5 38.0 
Anticonvulsants  34.5 32.0 
Benzodiazepines  16.6 14.0 
Cannabinoids  0.8 0.3 
^ For those patients taking opioid medication  *Number for (Enterprise One, All services) 
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Table 5  Employment status (percentage) at referral 
Employment status  
 
Enterprise One All Services 
n=445 n=19161 
Working full-time 12.6 16.9 
Working part-time 11.2 13.8 
Unable to work due to pain  40.2 38.6 
Unable to work due to a condition other than pain 13.9 12.7 
Not working by choice 20.4 16.1 
Seeking employment 1.6 1.9 
Total 100.0 100.0 
 
Table 6  Work productivity and impairment (percentage) at referral 
Work productivity and impairment  
(v2 data only) 
Enterprise One All Services 
Work time missed due to pain (n=83, 5027)* 22.8 30.0 
Pain affected work productivity (n=94, 3894)* 58.1 59.1 
Overall work impairment (n=75, 3525)* 61.2 65.2 
*Number for (Enterprise One, All services) 
+For people who indicated working full or part-time 
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Section 2 — Patient outcomes 
Seven standardised assessment tools are used to measure patient outcomes (see Appendix D). In addition, 
pain frequency, health service use and time from referral to first contact have also been included as 
outcomes. Patients must have valid start and end scores for the outcome measure to be included in the 
tables below – therefore where the response is not stated they have been excluded from the calculation of 
percentages in this section.  
This section also includes the ten ePPOC benchmarks. The benchmarks show the percent of patients 
experiencing a clinically significant improvement or meeting predetermined conditions in the domain  
(see Appendix D). Benchmarks were revised in 2018 and a number of benchmark thresholds were raised.  
This is shown in the benchmark graphs where appropriate. This report also includes time series graphs, which 
show change in performance on each of the benchmarks over time. 
2.1 Standard assessment tools 
The following section reports change in the assessment tools for completed pathways, completed episodes 
and at 3-6 months following a completed episode.  
2.1.1 Change from pathway start to pathway end 
This section examines changes from the beginning to the end of the patient’s treatment pathway. 
Table 7 shows the average change in score on the assessment tools. Note that the number of patients may 
differ from those in Table 2, as other questionnaire types may be used in place of Pathway Start and End 
questionnaires. For example, if a pathway has ended and a Pathway End questionnaire has not been 
received, a recent, related questionnaire may be used instead. 
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Table 7  Assessment tools — Change from pathway start to pathway end 
Assessment tool 
Enterprise One 
n=122 
All Services 
n=5834 
Score at 
pathway start 
Average 
change 
Valid 
outcomes % 
Score at 
pathway start 
Average 
change 
Valid 
outcomes % 
BPI   
Worst pain 7.7     -0.7     98.4 7.6     -1.0     98.1 
Least pain 4.2     -0.7     97.5 4.0     -0.7     97.0 
Average pain 5.8     -0.7     95.1 5.7     -1.0     97.3 
Pain now 5.7     -0.8     96.7 5.6     -0.9     97.3 
Interference 6.3     -1.2    100.0 6.5     -1.5     98.6 
DASS   
Depression 18.0     -3.4     99.2 16.9     -4.5     97.1 
Anxiety 12.7     -1.8     98.4 11.7     -2.0     97.0 
Stress 19.2     -3.3     99.2 19.3     -4.0     96.9 
PCS   
Rumination 7.9     -1.8     95.1 8.3     -2.3     94.9 
Magnification 4.7     -0.9     94.3 4.9     -1.3     95.2 
Helplessness 11.5     -3.1     94.3 11.3     -3.3     94.0 
Total 24.2     -6.0     94.3 24.4     -6.9     96.5 
PSEQ*   
Total 23.6      8.0     96.7 23.5      7.9     97.7 
* Note: For the PSEQ assessment tool, a positive movement in score demonstrates an improvement in how confident patients are in 
their ability to perform activities despite the pain. 
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Figure 1  BPI Average Pain — Change from pathway start to pathway end 
 
Patients with at least moderate average pain at 
pathway start who make a clinically significant 
improvement at pathway end 
 Number Percentage 
Enterprise One (n=94) 21 22.3 
All Services (n=4385) 1301     29.7 
 
Figure 2  BPI Worst Pain — Change from pathway start to pathway end 
 
Patients with at least moderate worst pain at pathway 
start who make a clinically significant improvement at 
pathway end 
 Number Percentage 
Enterprise One (n=111) 19 17.1 
All Services (n=5416) 1246     23.0 
 
Figure 3  BPI Pain Interference — Change from pathway start to pathway end 
 
 
Patients with at least moderate pain interference at 
pathway start who make a clinically significant 
improvement at pathway end 
 Number Percentage 
Enterprise One (n=93) 52 55.9 
All Services (n=4802) 2871     59.8 
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Figure 4  DASS Depression — Change from pathway start to pathway end 
 
Patients with at least moderate depression at pathway 
start who make a clinically significant improvement at 
pathway end 
 Number Percentage 
Enterprise One (n=68) 28 41.2 
All Services (n=3123) 1729     55.4 
 
Figure 5  DASS Depression — Severity at pathway start and pathway end 
 
Figure 6  DASS Anxiety — Change from pathway start to pathway end 
 
Patients with at least moderate anxiety at pathway start 
who make a clinically significant improvement at 
pathway end 
 Number Percentage 
Enterprise One (n=62) 18 29.0 
All Services (n=2869) 1240     43.2 
 
Figure 7  DASS Anxiety — Severity at pathway start and pathway end 
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Figure 8  DASS Stress — Change from pathway start to pathway end 
 
Patients with at least moderate stress at pathway start 
who make a clinically significant improvement at 
pathway end 
 Number Percentage 
Enterprise One (n=58) 29 50.0 
All Services (n=2769) 1639     59.2 
 
Figure 9  DASS Stress — Severity at pathway start and pathway end 
 
Figure 10  PCS Total — Change from pathway start to pathway end 
 
Patients with at least high pain catastrophising at 
pathway start who make a clinically significant 
improvement at pathway end 
 Number Percentage 
Enterprise One (n=68) 29 42.6 
All Services (n=3432) 1862     54.3 
 
Figure 11  PCS Total — Severity at pathway start and pathway end 
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Figure 12  PSEQ Total — Change from pathway start to pathway end 
 
Patients with at least moderate pain self-efficacy at 
pathway start who make a clinically significant 
improvement at pathway end 
 Number Percentage 
Enterprise One (n=81) 40 49.4 
All Services (n=4211) 2002     47.5 
 
Figure 13  PSEQ Total — Severity at pathway start and pathway end 
 
Figure 14  Global rating of change at pathway end 
Overall* 
 
Physical* 
 
* -3 = Very much worse 
     0 = No change 
     3 = Very much better 
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Table 8 shows the start and change scores for the assessment tools by pathway type – this allows for comparison between outcomes for different types of 
pathways. Data are only included where the same patient responded to questions in both the pathway start and end questionnaires and the pathway has been 
ended. 
Table 8  Assessment tools — Pathway start score and change from pathway start to end by pathway type 
Assessment tool 
Enterprise One All Services 
Group Individual Concurrent One-off Group Individual Concurrent One-off 
n=27 n=8 n=87 n=0 n=1827 n=3307 n=651 n=49 
Start Change Start Change Start  Change Start Change Start Change Start Change Start Change Start  Change 
BPI   
Worst pain 7.8     -0.7      8.4     -0.8      7.6     -0.6       .        .  7.6     -0.5      7.6     -1.3      7.9     -0.9      7.7     -1.1 
Least pain 4.4      0.0      4.0     -0.6      4.1     -0.9       .        .  3.9     -0.3      3.9     -0.9      4.5     -0.8      4.0     -0.8 
Average pain 6.1     -0.5      5.6     -0.8      5.7     -0.8       .        .  5.7     -0.5      5.7     -1.2      6.1     -0.9      5.8     -1.0 
Pain now 6.4     -0.6      5.4     -1.4      5.5     -0.8       .        .  5.7     -0.4      5.5     -1.2      6.1     -1.0      5.4     -1.2 
Interference 6.8     -1.2      6.1     -0.4      6.2     -1.2       .        .  6.5     -1.1      6.4     -1.8      7.0     -1.6      6.3     -1.1 
DASS   
Depression 18.3     -0.5     12.0     -2.5     18.4     -4.4       .        .  17.7     -3.9     15.5     -4.6     21.2     -5.7     13.6      0.0 
Anxiety 11.8     -1.6      7.3      0.0     13.5     -2.0       .        .  12.6     -1.6     10.7     -2.2     14.8     -2.1      8.8     -0.3 
Stress 19.7     -2.9     18.3     -0.8     19.1     -3.7       .        .  19.6     -3.0     18.5     -4.5     22.5     -4.8     15.1     -2.2 
PCS   
Rumination 7.6     -0.6      8.6     -2.4      8.0     -2.1       .        .  8.2     -1.9      8.0     -2.4      9.8     -2.8      8.3     -1.4 
Magnification 4.2     -0.1      3.6     -0.2      5.0     -1.2       .        .  4.9     -1.1      4.6     -1.4      6.0     -1.7      4.5     -0.8 
Helplessness 11.0     -1.8     10.3     -2.9     11.8     -3.5       .        .  11.6     -2.9     10.8     -3.4     13.3     -3.9     11.0     -1.8 
Total 22.9     -2.7     22.5     -6.3     24.7     -6.9       .        .  24.8     -5.8     23.4     -7.2     29.1     -8.3     23.7     -4.0 
PSEQ*   
Total 24.3      4.2     21.1     19.7     23.7      8.1       .        . 23.8      6.2     23.9      8.7     20.2      8.7     23.5      4.0 
* Note: For the PSEQ assessment tool, a positive movement in score demonstrates an improvement in how confident patients are in their ability to perform activities despite the pain. 
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Table 9 shows the start and change in average assessment tool scores for patients who completed group programs (either alone or part of a concurrent pathway) by 
the program intensity. Data are only included where the same patient completed both a questionnaire at the beginning and end of the group program and where 
group program service event data is entered for that patient. 
Table 9  Assessment tools, group programs — Group start score and change from start to end by program intensity 
Assessment tool 
Enterprise One All Services 
Low Intensity 
(6 to <24 hrs) 
Mod Intensity 
(24 to <60 hrs) 
High Intensity 
(60+ hrs) 
Low Intensity 
(6 to <24 hrs) 
Mod Intensity 
(24 to <60 hrs) 
High Intensity 
(60+ hrs) 
n=27 n=1 n=0 n=381 n=407 n=362 
Start Change Start Change Start Change Start Change Start Change Start Change 
BPI   
Worst pain 7.8     -1.1      9.0      0.0       .        .  7.4     -0.5      7.5     -0.6      7.7     -0.3 
Least pain 4.3     -0.2      5.0      2.0       .        .  4.0     -0.5      3.7     -0.3      4.3     -0.4 
Average pain 6.1     -0.8      5.0      3.0       .        .  5.6     -0.5      5.6     -0.6      5.9     -0.5 
Pain now 6.4     -0.8      6.0      2.0       .        .  5.5     -0.6      5.5     -0.5      5.9     -0.4 
Interference 6.7     -1.6     10.0     -1.1       .        .  6.2     -1.1      6.4     -1.2      6.8     -1.3 
DASS   
Depression 17.3     -2.1     36.0      2.0       .        .  16.5     -2.8     17.3     -4.0     20.4     -5.4 
Anxiety 12.4     -2.8      9.3      2.7       .        .  12.4     -1.5     12.4     -1.6     13.9     -2.1 
Stress 19.7     -4.5     30.0      4.0       .        .  18.6     -2.6     19.4     -2.9     21.7     -3.6 
PCS   
Rumination 7.5     -1.0      8.0      4.0       .        .  7.7     -1.5      8.0     -2.2      8.9     -2.3 
Magnification 3.9     -0.3      5.0      1.0       .        .  4.7     -1.0      4.9     -1.3      5.2     -1.4 
Helplessness 10.6     -2.3     13.0      3.0       .        .  10.8     -2.3     10.9     -2.9     12.6     -3.7 
Total 22.3     -3.9     26.0      8.0       .        .  23.1     -4.7     23.8     -6.3     26.8     -7.3 
PSEQ*   
Total 25.1      6.2     18.0     -2.0       .        . 25.8      5.1     24.4      6.0     21.1      9.2 
* Note: For the PSEQ assessment tool, a positive movement in score demonstrates an improvement in how confident patients are in their ability to perform activities despite the pain. 
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2.1.2 Change from referral to episode end 
Measurement of change from referral to the end of the episode (end of the final pathway in an episode) 
allows evaluation of change for patients who complete an episode of care at a pain management service. 
Table 10 shows the average change for patients completing the assessment tools at referral and episode end. 
Responses have only been included if the same patient returned a referral questionnaire and another at the 
end of their episode, and the end questionnaire was completed in the reporting period. 
Table 10  Assessment tools — Change from referral to episode end 
Assessment tool 
Enterprise One 
n=112 
All Services 
n=5572 
Score at 
referral 
Average 
change 
Valid 
outcomes % 
Score at 
referral 
Average 
change 
Valid 
outcomes % 
BPI   
Worst pain 7.9     -1.1     96.4 7.7     -1.2     97.8 
Least pain 4.3     -0.8     94.6 4.0     -0.8     96.8 
Average pain 6.1     -1.1     93.8 5.8     -1.1     97.2 
Pain now 5.8     -1.0     94.6 5.7     -1.1     96.9 
Interference 7.0     -1.9     98.2 6.7     -1.8     98.3 
DASS   
Depression 20.3     -5.7     95.5 17.4     -5.2     96.7 
Anxiety 13.2     -2.7     93.8 11.7     -2.2     96.6 
Stress 20.8     -5.0     95.5 19.5     -4.5     96.4 
PCS   
Rumination 9.0     -3.1     92.0 8.5     -2.6     94.7 
Magnification 5.3     -1.7     91.1 5.0     -1.5     95.0 
Helplessness 12.6     -4.2     90.2 11.7     -3.8     93.5 
Total 26.9     -9.0     91.1 25.2     -8.0     96.1 
PSEQ*   
Total 21.0     10.9     95.5 22.7      9.0     97.4 
* Note: For the PSEQ assessment tool, a positive movement in score demonstrates an improvement in how confident patients are in 
their ability to perform activities despite the pain. 
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Figure 15  BPI Average Pain — Change from referral to episode end 
 
Patients with at least moderate average pain at referral 
who make a clinically significant improvement at 
episode end 
 Number Percentage 
Enterprise One (n=89) 26 29.2 
All Services (n=4277) 1442     33.7 
 
Figure 16  BPI Worst Pain — Change from referral to episode end 
 
Patients with at least moderate worst pain at referral 
who make a clinically significant improvement at 
episode end 
 Number Percentage 
Enterprise One (n=106) 27 25.5 
All Services (n=5200) 1300     25.0 
 
Figure 17  Benchmark 1 — Average Pain 
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Figure 18  BPI Pain Interference — Change from referral to episode end 
 
 
Patients with at least moderate pain interference at 
referral who make a clinically significant improvement 
at episode end 
 Number Percentage 
Enterprise One (n=100) 68 68.0 
All Services (n=4694) 2978     63.4 
 
Figure 19  Benchmark 2 — Pain interference 
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Figure 20  DASS Depression — Change from referral to episode end 
 
Patients with at least moderate depression at referral 
who make a clinically significant improvement at 
episode end 
 Number Percentage 
Enterprise One (n=69) 35 50.7 
All Services (n=3080) 1839     59.7 
 
Figure 21  DASS Depression — Severity at referral and episode end 
 
 
Figure 22  Benchmark 3 — Depression 
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Figure 23  DASS Anxiety — Change from referral to episode end 
 
Patients with at least moderate anxiety at referral who 
make a clinically significant improvement at episode 
end 
 Number Percentage 
Enterprise One (n=54) 23 42.6 
All Services (n=2732) 1254     45.9 
 
Figure 24  DASS Anxiety — Severity at referral and episode end 
 
 
Figure 25  Benchmark 4 — Anxiety 
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Figure 26  DASS Stress — Change from referral to episode end 
 
Patients with at least moderate stress at referral who 
make a clinically significant improvement at episode 
end 
 Number Percentage 
Enterprise One (n=59) 34 57.6 
All Services (n=2681) 1656     61.8 
 
Figure 27  DASS Stress — Severity at referral and episode end 
 
 
Figure 28  Benchmark 5 — Stress 
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Figure 29  PCS Total — Change from referral to episode end 
 
Patients with at least high pain catastrophising at 
referral who make a clinically significant improvement 
at episode end 
 Number Percentage 
Enterprise One (n=74) 45 60.8 
All Services (n=3377) 1987     58.8 
 
Figure 30  PCS Total — Severity at referral and episode end 
 
 
Figure 31  Benchmark 6 — Pain Catastrophising 
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Figure 32  PSEQ Total — Change from referral to episode end 
 
Patients with at least moderate pain self-efficacy at 
referral who make a clinically significant improvement 
at episode end 
 Number Percentage 
Enterprise One (n=86) 47 54.7 
All Services (n=4079) 2119     51.9 
 
Figure 33  PSEQ Total — Severity at referral and episode end 
 
 
Figure 34  Benchmark 7 — Pain self-efficacy 
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Figure 35  Global rating of change at episode end 
Overall* 
 
Physical* 
 
* -3 = Very much worse 
     0 = No change 
     3 = Very much better 
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2.1.3 Change from referral to post episode  
This section describes change occurring from referral to a pain management service to a point three to  
six months after the patients’ episode has ended. This allows evaluation of the changes made as a result of 
the treatment received, and if these changes have been maintained. 
Table 11 shows the average change in the outcome measures for patients who completed both a referral and 
three to six month post episode questionnaire (and where the post episode questionnaire was completed 
within the reporting period). 
Table 11  Assessment tools — Change from referral to post episode 
Assessment tool 
Enterprise One 
n=39 
All Services 
n=2454 
Score at 
referral 
Average 
change 
Valid outcome 
% 
Score at 
referral 
Average 
change 
Valid outcome 
% 
BPI   
Worst pain 7.8     -0.4     89.7 7.7     -1.2     97.7 
Least pain 4.5     -0.6     89.7 4.0     -0.7     97.0 
Average pain 6.2     -0.8     89.7 5.8     -1.0     97.1 
Pain now 6.3     -1.0     87.2 5.6     -0.9     96.7 
Interference 6.7     -1.6     92.3 6.6     -1.7     98.0 
DASS   
Depression 17.4     -5.2     87.2 17.1     -4.6     96.5 
Anxiety 11.6     -2.0     84.6 11.5     -2.1     96.1 
Stress 18.3     -4.9     87.2 19.3     -4.5     95.9 
PCS   
Rumination 8.0     -2.6     87.2 8.6     -2.8     93.4 
Magnification 4.5     -1.5     89.7 4.9     -1.5     93.5 
Helplessness 10.8     -3.6     84.6 11.7     -3.8     92.5 
Total 23.6     -8.2     89.7 25.3     -8.1     95.1 
PSEQ*   
Total 23.8      6.8     89.7 23.1      8.5     96.9 
* Note: For the PSEQ assessment tool, a positive movement in score demonstrates an improvement in how confident patients are in 
their ability to perform activities despite the pain. 
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Figure 36  BPI Average Pain — Change from referral to post episode 
 
Patients with at least moderate average pain at referral 
who make a clinically significant improvement at post 
episode 
 Number Percentage 
Enterprise One (n=29) 7 24.1 
All Services (n=1853) 606     32.7 
 
Figure 37  BPI Worst Pain — Change from referral to post episode 
 
Patients with at least moderate worst pain at referral 
who make a clinically significant improvement at post 
episode 
 Number Percentage 
Enterprise One (n=33) 4 12.1 
All Services (n=2284) 565     24.7 
 
Figure 38  BPI Pain Interference — Change from referral to post episode 
 
 
Patients with at least moderate pain interference at 
referral who make a clinically significant improvement 
at post episode 
 Number Percentage 
Enterprise One (n=32) 21 65.6 
All Services (n=2051) 1219     59.4 
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Figure 39  DASS Depression — Change from referral to post episode 
 
Patients with at least moderate depression at referral 
who make a clinically significant improvement at post 
episode 
 Number Percentage 
Enterprise One (n=21) 14 66.7 
All Services (n=1338) 776     58.0 
 
Figure 40  DASS Depression — Severity at referral and post episode 
 
Figure 41  DASS Anxiety — Change from referral to post episode 
 
Patients with at least moderate anxiety at referral who 
make a clinically significant improvement at post 
episode 
 Number Percentage 
Enterprise One (n=16) 8 50.0 
All Services (n=1164) 553     47.5 
 
Figure 42  DASS Anxiety — Severity at referral and post episode 
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Figure 43  DASS Stress — Change from referral to post episode 
 
Patients with at least moderate stress at referral who 
make a clinically significant improvement at post 
episode 
 Number Percentage 
Enterprise One (n=13) 9 69.2 
All Services (n=1152) 703     61.0 
 
Figure 44  DASS Stress — Severity at referral and post episode 
 
Figure 45  PCS Total — Change from referral to post episode 
 
Patients with at least high pain catastrophising at 
referral who make a clinically significant improvement 
at post episode 
 Number Percentage 
Enterprise One (n=22) 14 63.6 
All Services (n=1458) 844     57.9 
 
Figure 46  PCS Total — Severity at referral and post episode 
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Figure 47  PSEQ Total — Change from referral to post episode 
 
Patients with at least moderate pain self-efficacy at 
referral who make a clinically significant improvement 
at post episode 
 Number Percentage 
Enterprise One (n=26) 12 46.2 
All Services (n=1752) 879     50.2 
 
Figure 48  PSEQ Total — Severity at referral and post episode 
 
Figure 49  Global rating of change at post episode 
Overall* 
 
Physical* 
 
* -3 = Very much worse 
     0 = No change 
     3 = Very much better 
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2.2 Outcome measure 2 — Medication use 
Pain management services collect information about the medications their patients take and the frequency 
of their use. This information is provided to ePPOC as three variables, describing: 
 whether or not a patient uses opioid medication on more than two days per week 
 the patient’s oral morphine equivalent daily dose (using a standardised conversion table) 
 the number and type of major drug groups the patient’s medications fall within. The major drug 
groups are opioids, paracetamol, NSAIDs, antidepressants, anticonvulsants, benzodiazepines 
(including Z drugs) and medicinal cannabinoids. 
Table 12 and Table 13 show the change in medication use for Enterprise One patients compared to patients 
for All Services from referral to episode end and referral to post episode end.  
Table 12  Medication use — Change from referral to episode end 
Medication use 
 
Enterprise One All Services 
Referral Episode end Referral Episode end 
Percent using opioids >2 days/week (n=32, 2821)* 62.5  59.4 52.0  40.7 
oMEDD (mg) ^ (n=20, 1413)*   
Average  47.4  29.0 51.6  37.4 
Median   42.0  17.0  30.0  16.0 
Ave number of major drug groups (n=34, 3228)* 2.7   2.3 2.3   2.1 
^ For those patients taking opioid medication 
*Number for (Enterprise One, All services) 
Figure 50  Medication use at referral and episode end 
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Figure 51  Benchmark 8 — Opioid Use, all 
  
Figure 52  Benchmark 9 — Opioid Use, high dose 
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Table 13  Medication use — Change from referral to post episode 
Medication use 
 
Enterprise One All Services 
Referral Post  
episode 
Referral Post 
episode 
Percent using opioids >2 days/week (n=11, 1279)* 72.7  54.5 53.4  40.5 
oMEDD (mg) ^  (n=8, 654)*   
Average 52.4  21.1 55.4  37.9 
Median  46.5   7.5  30.0  15.0 
Ave number of major drug groups (n=11, 1386)* 3.0   2.5 2.5   2.1 
^ For those patients taking opioid medication 
*Number for (Enterprise One, All services) 
Figure 53  Medication use at referral and post episode 
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2.3 Outcome measure 3 — Work status and productivity 
Table 14 to Table 17 show outcome data related to work status and productivity over two time periods:  
 Referral to episode end (where referral and final pathway end questionnaires have been completed, 
and the episode has been ended) 
 Referral to post episode (where referral and post episode questionnaires have been completed). 
To be included in each of these tables, the same patient must have completed a referral and end of outcome 
period questionnaire in this reporting period. 
Table 14  Employment status (percentage) — referral to episode end 
Employment status  
 
Enterprise One All Services 
Referral Episode end Referral Episode end 
n=64 n=4106 
Working full-time 12.5   7.8 20.4  21.0 
Working part-time 7.8  15.6 16.2  17.7 
Unable to work due to pain  46.9  42.2 42.2  35.8 
Unable to work due to a condition other 
than pain 
7.8   7.8 9.3   9.4 
Not working by choice 21.9  20.3 10.3  11.9 
Seeking employment 3.1   6.3 1.7   4.3 
Total 100.0 100.0 100.0 100.0 
 
Table 15 Work productivity and impairment (percentage) — referral to episode end 
Work productivity and impairment  
 
Enterprise One All Services 
Referral Episode end Referral Episode end 
Work time missed due to pain  
(n=9, 1009)* 
35.5  11.3 30.7  18.0 
Pain affected work productivity  
(n=10, 629)* 
53.0  41.0 57.2  39.4 
Overall work impairment (n=8, 552)* 61.2  41.4 64.3  44.5 
*Number for (Enterprise One, All services) 
+For people who indicated working full or part-time 
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Table 16  Employment status (percentage) — referral to post episode 
Employment status 
 
Enterprise One All Services 
Referral Post episode Referral Post episode 
n=18 n=1295 
Working full-time 11.1  11.1 19.0  20.8 
Working part-time 5.6   5.6 16.2  16.4 
Unable to work due to pain  50.0  38.9 42.5  33.1 
Unable to work due to a condition other 
than pain 
5.6   5.6 8.2   9.3 
Not working by choice 27.8  27.8 12.9  14.8 
Seeking employment 0.0  11.1 1.2   5.6 
Total 100.0 100.0 100.0 100.0 
 
Table 17 Work productivity and impairment (percentage) — referral to post episode 
Work productivity and impairment  
 
Enterprise One All Services 
Referral Post episode Referral Post episode 
Work time missed due to pain  
(n=2, 283)* 
3.7   4.5 26.4  11.5 
Pain affected work productivity  
(n=2, 189)* 
25.0  20.0 52.7  37.4 
Overall work impairment  (n=2, 168)* 26.9  23.6 59.7  40.1 
*Number for (Enterprise One, All services) 
 
2.4 Outcome measure 4 — Health service use 
Table 18 shows the median and mean number of times Enterprise One patients used each service in the last 
three months compared to All Services for patients who returned a questionnaire at referral, episode end, 
and/or post episode in the reporting period.  
Table 18  Health service use (number of times used in the last 3 months due to pain) 
Health service use (median / mean) 
Enterprise One All Services 
Referral Episode 
end 
Post 
episode 
Referral Episode 
end 
Post 
episode 
n=473 n=122 n=38 n=20763 n=5562 n=2458 
General practitioner 4.0 / 4.7   2.0 / 3.3   2.0 / 2.5 3.0 / 4.6   2.0 / 2.8   2.0 / 2.5 
Medical specialist 0.0 / 1.0   0.0 / 0.7   0.0 / 0.6 1.0 / 1.3   0.0 / 1.0   0.0 / 0.8 
Other health professionals  1.0 / 3.0   1.0 / 3.6   1.0 / 2.2 2.0 / 4.7   3.0 / 6.1   1.0 / 3.7 
Hospital emergency department 0.0 / 0.7   0.0 / 0.2   0.0 / 0.0 0.0 / 0.5   0.0 / 0.2   0.0 / 0.1 
Admitted to hospital 0.0 / 0.3   0.0 / 0.1   0.0 / 0.0 0.0 / 0.2   0.0 / 0.1   0.0 / 0.1 
Diagnostic tests 1.0 / 1.2   0.0 / 0.7   0.0 / 0.6 1.0 / 1.4   0.0 / 0.7   0.0 / 0.5 
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2.5 Outcome measure 5 — Pain frequency 
Table 19 and Figure 54 show the percentage of patients at each level of pain frequency for patients who 
returned a referral, episode end, and/or post episode questionnaire in the reporting period.  
Table 19  Pain frequency (percentage) 
Pain frequency 
Enterprise One All Services 
Referral Episode  
end 
Post  
episode 
Referral Episode  
end 
Post  
episode 
n=484 n=121 n=40 n=20824 n=5538 n=2448 
Always present (same intensity) 18.8   7.4  10.0 15.5   6.5   7.4 
Always present (varying intensity) 71.9  62.0  60.0 70.4  56.4  56.2 
Often present 6.6  20.7  12.5 9.7  16.3  14.4 
Occasionally present 2.1   6.6  15.0 3.0  12.2  11.0 
Rarely present 0.6   2.5   2.5 1.4   7.5   9.4 
Pain no longer present 0.0   0.8   0.0 0.0   1.2   1.6 
Total 100.0 100.0 100.0 100.0 100.0 100.0 
 
Figure 54  Pain frequency 
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2.6 Outcome measure 6 — Time from referral to episode start 
Table 20 shows the distribution of time from referral to episode start for Enterprise One compared to All 
Services for episodes that start within the reporting period. The time from referral to episode start is 
calculated as the date the referral is received to the episode start date (defined as the first clinical contact). 
Table 20  Time from referral to episode start 
Time from referral to episode start 
Enterprise One All Services 
Number Percentage Number Percentage 
<1 month 56     15.6 5505     33.7 
1-3 months 147     40.8 5061     31.0 
3-6 months 120     33.3 3466     21.2 
6-12 months 26      7.2 1754     10.7 
>12 months 11      3.1 535      3.3 
Average (days) 107.3 na 96.7 na 
Median (days) 83.0 na 60.0 na 
Within 8 weeks (wait time indicator) 104     28.9 7775     47.6 
Within 3 months (wait time benchmark) 203     56.4 10,566     64.7 
 
Figure 55 shows the position of Enterprise One in comparison to other services based on the time from 
referral to episode start. The horizontal axis shows pain management services ordered from lowest to 
highest by number of days. This figure also displays the number of referral questionnaires returned in the 
reporting period as a proxy for the number of referrals the service received. 
Figure 55  Median number of days from referral to episode start 
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Figure 56  Benchmark 10 — Waiting time 
  
Note: If there is no red dot on your graph this indicates that your service reported less than 10 outcomes for this benchmark 
Figure 57  Wait time indicator 
  
Note: If there is no red dot on your graph this indicates that your service reported less than 10 outcomes for this indicator 
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Section 3 — Descriptive analysis 
There are four levels of ePPOC data items – patient, episode, pathway and service events. The broad detail is 
found at the patient level, where the data items describe patient demographics. 
The items at the episode level describe the way that pain management episodes start and end and include 
information about the patient’s pain and comorbidities at the start of the episode. The items at the pathway 
level categorise the type of treatment(s) the patient received, while the service event data items detail this 
treatment and allow evaluation of the intensity of the treatment provided. 
This section provides an overview of the data submitted by Enterprise One at each level for the current 
reporting period. Summaries of the data for All Services are included for comparative purposes.  
See Supplementary Data 1 for information on item completion. 
3.1 Summary of service events during this reporting period 
Table 21 describes the service event activity for Enterprise One between 1 July 2108 and 30 June 2019. 
Table 21  Service event activity this reporting period 
Service duration (total hours) 
Enterprise One 
Total Telehealth 
Individual appointment with medical practitioner 126.5      0.0 
Individual appointment with physiotherapist 541.0      0.0 
Individual appointment with psychologist 190.5      0.0 
Individual appointment with occupational therapist 218.0      0.0 
Individual appointment with nurse 0.0      0.0 
Individual appointment with one or more clinicians 0.0      0.0 
Individual appointment – other 7.0      0.0 
Multidisciplinary team assessment 18.5      0.0 
Multidisciplinary panel discussion 3.2      0.0 
Telephone/email consultation with patient/carer 5.0      0.0 
Telephone/email consultation with another clinician 1.0      0.0 
Pain management program – group 769.0      0.0 
Pain management program – individual 13.0      0.0 
Procedural intervention – implant (drug delivery) 0.0      0.0 
Procedural intervention – implant (neurostimulation) 0.0      0.0 
Procedural intervention – non-implant 0.0      0.0 
Procedural intervention – cancer block 0.0      0.0 
Procedural intervention – other 0.0      0.0 
Education/orientation program 118.0      0.0 
Other 2.0      0.0 
Total 2012.7      0.0 
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Figure 58  Highest duration service events by type this reporting period (as a percent of your service’s total 
hours) 
 
  
 
       
Patient Outcomes in Pain Management, 2019 Mid Year Report 
39 
3.2 Profile of pain management patients 
The information collected about each patient includes gender, indigenous status, country of birth, whether 
an interpreter is required and if a patient requires help with communication. 
Table 22 to Table 26 describe patients at Enterprise One compared to those at All Services for patients active 
in the reporting period.  
Table 22  Gender  
Gender 
Enterprise One All Services 
Number Percentage Number Percentage 
Male 247     36.3 13646     42.3 
Female 420     61.8 18536     57.5 
Not stated/inadequately described 13      1.9 70      0.2 
Total 680    100.0 32252    100.0 
 
Table 23  Indigenous status  
Indigenous status 
Enterprise One All Services 
Number Percentage Number Percentage 
Aboriginal but not Torres Strait Islander 43      7.8 829      4.0 
Torres Strait Islander but not Aboriginal 0      0.0 36      0.2 
Both Aboriginal & Torres Strait Islander 0      0.0 9      0.0 
Neither Aboriginal nor Torres Strait Islander 507     92.2 19744     95.8 
Total 550    100.0 20618    100.0 
 
Table 24  Country of birth  
Country of birth 
Enterprise One All Services 
Number Percentage Number Percentage 
Australia 450     69.4 15391     51.3 
New Zealand 72     11.1 7040     23.4 
Other 126     19.4 7597     25.3 
Total 648    100.0 30028    100.0 
 
Figure 59  Socioeconomic disadvantage quintile (based on patient area of residence) 
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Table 25  Interpreter required  
Interpreter required 
Enterprise One All Services 
Number Percentage Number Percentage 
Yes 11      1.7 1189      4.0 
No 637     98.3 28503     96.0 
Total 648    100.0 29692    100.0 
 
Table 26  Communication assistance 
Assistance required with communication 
Enterprise One All Services 
Number Percentage Number Percentage 
Yes 55      8.8 2237      7.8 
No 567     91.2 26509     92.2 
Total 622    100.0 28746    100.0 
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3.3 Profile of pain management episodes 
An episode of care is a period of contact between a patient and a pain management service. An episode of 
pain management begins with the first clinical contact with the patient and ends when active treatment is 
completed or discontinued at your pain service. 
In the following tables episodes at Enterprise One are described in comparison to those at All Services for 
active episodes in the reporting period. 
Table 27  Referral source 
Referral source 
Enterprise One All Services 
Number Percentage Number Percentage 
General practitioner/nurse practitioner  
(not an admitted patient) 
486     70.5 17356     53.1 
Specialist practitioner (not an admitted patient) 45      6.5 5425     16.6 
Other pain management service 3      0.4 1397      4.3 
Public hospital  
(incl. emergency or outpatient department) 
96     13.9 2416      7.4 
Private hospital  
(incl. emergency or outpatient department) 
0      0.0 46      0.1 
Rehabilitation provider/private insurer 36      5.2 2538      7.8 
Other 23      3.3 3514     10.7 
Total 689    100.0 32692    100.0 
 
Table 28  Episode start mode 
Episode start mode 
 
Enterprise One All Services 
Number Percentage Number Percentage 
Multidisciplinary assessment and/or treatment 87     17.6 9128     40.4 
Single clinician assessment and/or treatment 50     10.1 8197     36.3 
Education/orientation Program 358     72.3 5252     23.3 
Total 495    100.0 22577    100.0 
 
Table 29  Episode end mode 
Episode end mode 
Enterprise One All Services 
Number Percentage Number Percentage 
Treatment complete – self management/referral to 
primary care 
106     57.3 5931     52.4 
Referral to another pain service 3      1.6 279      2.5 
Patient discontinued by choice 26     14.1 1544     13.7 
Died 2      1.1 25      0.2 
Active treatment complete – ongoing review 34     18.4 1959     17.3 
Referral did not proceed to episode start  10      5.4 1211     10.7 
Lost to contact/Not to follow-up  4      2.2 361      3.2 
Other (v1 only) 0      0.0 1      0.0 
Total 185    100.0 11311    100.0 
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Table 30  Length of episode — summary 
Length of episode Enterprise One All Services 
Average length of episode (days) 240.1 206.6 
Median length of episode (days) 232.0 138.0 
 
Table 31  Length of episode — distribution 
Length of episode 
Enterprise One All Services 
Number Percentage Number Percentage 
<1 month 27     12.6 2333     17.6 
1-2 months 11      5.1 1018      7.7 
3-6 months 53     24.7 5299     40.1 
7-9 months 26     12.1 1468     11.1 
10-12 months 56     26.0 1529     11.6 
>12 months 42     19.5 1575     11.9 
Total 215    100.0 13222    100.0 
 
Table 32  Number of pathways per episode 
Pathways per episode 
Enterprise One All Services 
Number Percentage Number Percentage 
1 207     96.3 12300     93.0 
2 8      3.7 691      5.2 
3 0      0.0 164      1.2 
4 0      0.0 46      0.3 
5 0      0.0 13      0.1 
6 0      0.0 7      0.1 
7 0      0.0 0      0.0 
8 or more 0      0.0 1      0.0 
Total 215    100.0 13222    100.0 
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Table 33  Service duration — time per episode (for completed episodes) 
Service duration (average hours) 
Enterprise One All Services 
Total Telehealth Total Telehealth 
Individual appointment with medical practitioner 1.2      0.0 1.2      0.0 
Individual appointment with physiotherapist 5.3      0.0 4.5      0.0 
Individual appointment with psychologist 2.0      0.0 1.4      0.0 
Individual appointment with occupational therapist 1.8      0.0 0.7      0.0 
Individual appointment with nurse 0.0      0.0 0.1      0.0 
Individual appointment with one or more clinicians 0.0      0.0 0.1      0.0 
Individual appointment – other 0.1      0.0 0.2      0.0 
Multidisciplinary team assessment 0.1      0.0 0.7      0.0 
Multidisciplinary panel discussion 0.1      0.0 0.2      0.0 
Telephone/email consultation with patient/carer 0.1      0.0 0.1      0.0 
Telephone/email consultation with another clinician 0.0      0.0 0.0      0.0 
Pain management program – group 8.2      0.0 13.7      0.0 
Pain management program – individual 0.3      0.0 0.4      0.1 
Procedural intervention – implant (drug delivery) 0.0      0.0 0.0      0.0 
Procedural intervention – implant (neurostimulation) 0.0      0.0 0.0      0.0 
Procedural intervention – non-implant 0.0      0.0 0.0      0.0 
Procedural intervention – cancer block 0.0      0.0 0.0      0.0 
Procedural intervention – other 0.0      0.0 0.0      0.0 
Education/orientation program 0.5      0.0 0.6      0.0 
Other 0.0      0.0 0.1      0.0 
Total 19.6      0.0 24.1      0.1 
 
Table 34  Age at referral by gender 
Age at referral 
Enterprise One All Services 
Male Female Male Female 
Average age (years) 51.5     53.1 50.0     50.5 
Median age (years) 52.5     53.0 50.0     51.0 
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Table 35  Age group at referral by gender — distribution 
Age group 
at referral 
Enterprise One All Services 
Male Female Male Female 
Number Percentage Number Percentage Number Percentage Number Percentage 
< 18 1      0.4            0      0.0 37      0.3          135      0.7 
18-24 10      4.0           14      3.3 486      3.5          965      5.1 
25-34 27     10.8           45     10.6 1785     12.9         2281     12.2 
35-44 41     16.4           73     17.1 2678     19.4         3160     16.9 
45-54 60     24.0           89     20.9 3485     25.2         4596     24.5 
55-64 67     26.8           96     22.5 3158     22.8         3902     20.8 
65-74 27     10.8           68     16.0 1460     10.6         2281     12.2 
75-84 14      5.6           34      8.0 621      4.5         1172      6.3 
85+ 3      1.2            7      1.6 111      0.8          248      1.3 
Total 250    100.0          426    100.0 13821    100.0        18740    100.0 
 
Table 36  Body Mass Index (BMI) 
BMI 
Enterprise One All Services 
Number Percentage Number Percentage 
Underweight 12      2.7 461      2.0 
Normal weight 103     22.8 6061     25.9 
Overweight 126     27.9 7369     31.5 
Obese 211     46.7 9514     40.6 
Total 452    100.0 23405    100.0 
 
Table 37  Main pain area at referral 
Main pain area* 
Enterprise One All Services 
Number Percentage Number Percentage 
Head 22      4.4 1274      4.9 
Neck 34      6.9 2049      7.9 
Chest 6      1.2 436      1.7 
Back  222     44.8 11253     43.2 
Leg 32      6.5 1704      6.5 
Arm/shoulder 54     10.9 3150     12.1 
Abdomen 11      2.2 851      3.3 
Hands 11      2.2 652      2.5 
Feet 17      3.4 1071      4.1 
Pelvic and/or genital 18      3.6 463      1.8 
Buttocks 0      0.0 5      0.0 
Knee 27      5.5 1206      4.6 
Hip 41      8.3 1940      7.4 
Total 495    100.0 26054    100.0 
* See Appendix D — Assessment tools for description of pain areas 
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Table 38  Number of pain areas at referral 
Number of pain areas 
Enterprise One All Services 
Number Percentage Number Percentage 
1 71     11.2 3781     12.6 
2-3 186     29.2 9985     33.4 
4-6 246     38.7 11165     37.4 
7-9 106     16.7 4165     13.9 
10+ 27      4.2 796      2.7 
Total 636    100.0 29892    100.0 
 
Table 39  Pain duration 
Pain duration 
Enterprise One All Services 
Number Percentage Number Percentage 
Less than 3 months 9      1.4 1003      3.4 
3 to 12 months 60      9.5 5472     18.6 
12 months to 2 years 76     12.0 4602     15.6 
2 to 5 years 143     22.7 6495     22.0 
More than 5 years 343     54.4 11918     40.4 
Total 631    100.0 29490    100.0 
 
Table 40  How main pain began (precipitating event) 
How main pain began 
Enterprise One All Services 
Number Percentage Number Percentage 
Injury at home 54      8.6 3309     11.2 
Injury at work/school 130     20.8 7457     25.3 
Injury in another setting 47      7.5 2744      9.3 
After surgery 71     11.4 2396      8.1 
Motor vehicle crash 54      8.6 3015     10.2 
Related to cancer 2      0.3 333      1.1 
Related to another illness 64     10.2 3221     10.9 
No obvious cause 102     16.3 4171     14.2 
Other 101     16.2 2809      9.5 
Total 625    100.0 29455    100.0 
 
Table 41  Cancer pain  
Cancer pain (is this episode of care for the 
management of cancer pain?) 
Enterprise One All Services 
Number Percentage Number Percentage 
Yes 1      0.2 147      0.5 
No 658     99.8 30226     99.5 
Total  659    100.0 30373    100.0 
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Table 42  Comorbidities  
Comorbidities 
Enterprise One All Services 
Number Percentage* Number Percentage* 
Mental health condition 315     45.7 12671     38.8 
 PTSD 56      8.1 2472      7.6 
 Anxiety 201     29.2 7143     21.8 
 Depression 247     35.8 10287     31.5 
Arthritis 312     45.3 10385     31.8 
Muscle, bone and joint problems other than arthritis 150     21.8 8462     25.9 
Heart and circulation problems  198     28.7 7129     21.8 
 High Blood Pressure 129     18.7 4491     13.7 
 High Cholesterol 38      5.5 1846      5.6 
Diabetes 78     11.3 2993      9.2 
Digestive problems 189     27.4 6957     21.3 
Respiratory problems  163     23.7 6174     18.9 
Neurological problems  65      9.4 2207      6.8 
Cancer 31      4.5 1149      3.5 
Liver, kidney and pancreas problems  43      6.2 1894      5.8 
Thyroid problems  51      7.4 2097      6.4 
Other medical conditions 142     20.6 5629     17.2 
* Note that the percentages in this table will not sum to 100% as patients may have more than one comorbidity. 
 
Table 43  Compensation case  
Compensation case 
Enterprise One All Services 
Number Percentage Number Percentage 
Yes 46      8.4 3792     18.3 
No 501     91.6 16984     81.7 
Total  547    100.0 20776    100.0 
 
Table 44  Australian Defence Force service  
Australian Defence Force service 
Enterprise One All Services 
Number Percentage Number Percentage 
Yes 15      3.2 627      3.7 
No 458     96.8 16475     96.3 
Total  473    100.0 17102    100.0 
 
Table 45  Department of Veterans’ Affairs client 
Department of Veterans’ Affairs client 
Enterprise One All Services 
Number Percentage Number Percentage 
Yes 7      1.5 389      2.3 
No 465     98.5 16637     97.7 
Total  472    100.0 17026    100.0 
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3.4 Profile of pain management pathways 
The pain management pathway describes the broad type of intervention provided to the patient. There are 
four pain management pathway types:  
 group pain management program(s) 
 individual appointment(s) 
 concurrent (both group and individual appointments) 
 one-off intervention. 
Each episode would generally include one or more pathway, and the pathways can occur in any sequence.  
Table 46 to Table 48 present information on active pathways within an episode. 
Table 46  Number of pathways by pathway type 
Pathway type 
Enterprise One All Services 
Number Percentage Number Percentage 
Group 34     14.0 3794     23.2 
Individual 36     14.9 11023     67.3 
Concurrent 172     71.1 1456      8.9 
One-off 0      0.0 106      0.6 
All pathways 242    100.0 16379    100.0 
 
Table 47  Average pathway length (in days) by pathway type 
Pathway type Enterprise One All Services 
Group 37.6 48.1 
Individual 204.2 177.9 
Concurrent 218.7 154.7 
One-off . 96.1 
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Table 48  Service duration — time per pathway (for completed pathways) 
Service duration (average hours) 
Enterprise One All Services 
Total Telehealth Total Telehealth 
Individual appointment with medical practitioner 1.3      0.0 0.9      0.0 
Individual appointment with physiotherapist 4.5      0.0 4.3      0.0 
Individual appointment with psychologist 1.8      0.0 1.4      0.0 
Individual appointment with occupational therapist 2.0      0.0 0.8      0.0 
Individual appointment with nurse 0.0      0.0 0.1      0.0 
Individual appointment with one or more clinicians 0.0      0.0 0.1      0.0 
Individual appointment – other 0.0      0.0 0.2      0.0 
Multidisciplinary team assessment 0.1      0.0 0.3      0.0 
Multidisciplinary panel discussion 0.0      0.0 0.0      0.0 
Telephone/email consultation with patient/carer 0.0      0.0 0.1      0.0 
Telephone/email consultation with another clinician 0.0      0.0 0.0      0.0 
Pain management program – group 8.1      0.0 12.7      0.0 
Pain management program – individual 0.3      0.0 0.5      0.1 
Procedural intervention – implant (drug delivery) 0.0      0.0 0.0      0.0 
Procedural intervention – implant (neurostimulation) 0.0      0.0 0.0      0.0 
Procedural intervention – non-implant 0.0      0.0 0.0      0.0 
Procedural intervention – cancer block 0.0      0.0 0.0      0.0 
Procedural intervention – other 0.0      0.0 0.0      0.0 
Education/orientation program 0.1      0.0 0.3      0.0 
Other 0.0      0.0 0.0      0.0 
Total 18.2      0.0 21.8      0.1 
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Supplementary data 1 — Item completion 
Many items collected in epiCentre are mandatory. This section contains item completion information on 
those variables that are not mandatory. 
Table 49 presents information on item completion for patients active within the reporting period. 
Table 49  Item completion (percent complete) — patient level 
Data item* Enterprise One All Services 
Indigenous status 82.7 94.5 
Country of birth 97.7 98.1 
Interpreter required 98.4 97.8 
Communication assistance 94.5 94.7 
* Percent of data items complete in referral questionnaires received in the reporting period 
 
Table 50 contains episode level item completion rates for episodes active in the reporting period. 
Table 50  Item completion (percent complete) — episode level 
Data item* Enterprise One All Services 
Main pain site 77.7 84.8 
How main pain began 94.7 97.0 
Pain duration 95.6 97.1 
Health service use    
General practitioner 93.2 95.0 
Medical specialist 88.3 91.7 
Other health professionals 89.4 91.3 
Hospital emergency department 86.0 89.5 
Admitted to hospital 84.6 88.7 
Diagnostic tests 87.6 91.1 
Pain frequency 96.8 96.5 
* Percent of data items complete in questionnaires received in the reporting period 
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Table 51 and Table 52 present assessment tool and questionnaire response rates for questionnaires returned 
in the reporting period. 
Table 51  Item completion — assessment tools 
Outcome 
measure 
Validity – 
Number of 
completed 
items 
required 
Enterprise One All Services 
Average number 
of completed 
items 
Percentage of 
validly completed 
questionnaires 
Average number 
of completed 
items 
Percentage of 
validly 
completed 
questionnaires 
BPI    
Worst pain 1/1 na     98.0 na     98.4 
Least pain 1/1 na     97.1 na     97.7 
Average pain 1/1 na     96.9 na     97.9 
Pain now 1/1 na     97.5 na     97.9 
Severity 4/4 3.9     96.1 3.9     96.6 
Interference 4/7 6.8     98.0 6.9     98.6 
DASS    
Depression 6/7 6.7     95.4 6.8     97.3 
Anxiety 6/7 6.7     94.2 6.8     97.1 
Stress 6/7 6.7     95.0 6.8     97.0 
PCS    
Rumination 4/4 3.8     93.9 3.9     96.0 
Magnification 3/3 2.8     93.2 2.9     95.9 
Helplessness 6/6 5.7     92.7 5.8     95.0 
Total 12/13 12.3     94.0 12.7     96.7 
PSEQ    
Total 9/10 9.6     94.4 9.8     97.5 
 
Table 52  Questionnaire response (percent returned) 
Questionnaire response* Enterprise One All Services 
Referral questionnaire 89.3 81.5 
Pathway start questionnaire 94.0 74.8 
Group program start (concurrent pathway) 98.6 91.6 
Pathway review 40.0 63.6 
Group program end (concurrent pathway) 97.0 77.8 
Pathway end questionnaire 84.9 73.4 
Post episode questionnaire 83.0 43.6 
Ad-hoc questionnaire 92.0 69.5 
* Number of questionnaires returned in the reporting period as a percentage of the number sent  
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Supplementary data 2 — Change in patient reported 
outcome measures from referral to first pathway 
start 
Table 53 shows changes in outcome measure scores for patients who have completed both a referral and 
pathway start questionnaire (for their first pathway). This information is included to allow pain management 
services to assess patient change in the time from referral to when active treatment begins. For example, 
long wait times may mean a patient’s condition deteriorates between referral and treatment start. 
Alternatively, this information may be used to assess whether interventions delivered prior to treatment 
pathways (e.g. short education programs and assessment appointments) are having an impact on patient 
outcomes.  
Table 53  Change in outcome measure scores between referral and first pathway start 
Outcome measure 
Enterprise One All Services 
n=64 n=1773 
Referral Change Referral Change 
BPI   
Severity§ 6.0     -0.1 6.2     -0.4 
Interference 6.7     -0.4 7.1     -0.6 
DASS   
Depression 18.3     -1.8 19.7     -1.8 
Anxiety 12.3      1.0 13.4     -0.1 
Stress 19.8     -1.1 20.6     -0.9 
PCS   
Total 27.9     -4.5 28.8     -3.6 
PSEQ*   
Total 22.7     -1.7 20.8     -2.8 
§ The severity score is an average of the four severity items 
* Note: For the PSEQ assessment tool, an increase in score is an improvement in how patients are able to perform activities despite 
the pain. 
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Appendix A — Data scoping 
The scope for the information in the ePPOC reports can be split into two types. The first looks at patient-level 
change over a pathway or episode. The second uses the activity during the reporting period. 
Change in patient outcomes over a pathway or episode 
Outcomes for episodes or pathways are only included where a patient completes both a start and end 
questionnaire, and the end questionnaire is completed within the reporting period. The start questionnaire 
does not necessarily need to be completed in the same reporting period. The following sections use this 
method; 
 Section 2.1 (Patient outcomes – Standard assessment tools)  
 Section 2.2 (Patient outcomes – Medication use)  
 Section 2.3 (Patient outcomes – Work status and productivity)  
Activity during the reporting period 
All other information is based on activity in the reporting period. Sections 3.2, 3.3 and 3.4 report on 
completed questionnaires in the reporting period. This means that the data in each column is not necessarily 
for the same patients. 
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Appendix B — Services included in ‘All Services’ 
New South Wales: 
 Central Coast Integrated Pain Service 
 Concord Repatriation Hospital Pain Clinic 
 Greenwich Hospital Pain Management Service 
 Hunter Integrated Pain Service 
 Innervate Pain Management 
 Illawarra-Shoalhaven Chronic Pain Service 
 Lismore Hospital Multidisciplinary Pain Management Clinic 
 Liverpool Hospital Chronic Pain Service 
 Nepean Hospital Pain Management Unit 
 Orange Base Hospital Chronic Pain Clinic 
 Port Macquarie Chronic Pain Service 
 Prince of Wales Pain Management Department 
 Royal North Shore Hospital Pain Service 
 Royal Prince Alfred Pain Management Service 
 St George Pain Management Unit 
 St Vincents Hospital Pain Clinic, Darlinghurst 
 Sydney Spine and Pain Rehab 
 Tamworth Integrated Pain Service 
 Westmead Hospital Pain Service 
 
New Zealand 
 Active Plus 
 Advantage South 
 APM Workcare 
 Auckland DHB (TARPS - Auckland Regional Hospital) 
 Body in Motion 
 Canterbury DHB (Burwood Hospital) 
 Capital and Coast DHB (Wellington) 
 Fit For Work 
 Futureproof Rehab 
 Habit Group 
 Hutt Valley DHB 
 Integrative Pain Care 
 Nelson Nursing Service 
 Occupational Health Canterbury 
 Pain Management and Rehabilitation Services Limited 
 Pain Rehabilitation Christchurch Ltd 
 Proactive Health 
 QE Health 
 Southern Rehab 
 Taranaki DHB 
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 TBI Health 
Queensland: 
 Interventus Pain Specialists 
 North Queensland Persistent Pain Management Service (Townsville Hospital) 
 Princess Alexandra Hospital – Metro South Health Persistent Pain Management Service 
 St Vincent’s Private Hospital Brisbane 
 Sunshine Coast Persistent Pain Management Service (Nambour Hospital) 
 The Wesley Hospital Brisbane 
 
South Australia: 
 Central Adelaide Local Health Network (Queen Elizabeth Hospital) 
 Flinders Medical Centre Pain Management Unit 
 Northern Pain Rehabilitation Service (Modbury Hospital) 
 
Victoria: 
 Advance Healthcare 
 Austin Pain Service (Austin Health) 
 Barbara Walker Centre for Pain Management, St Vincent’s Hospital Melbourne 
 Caulfield Pain Management and Research Centre (Alfred Health) 
 Dorset Rehabilitation Centre 
 Eastern Health Pain Management Service 
 Empower Rehab 
 Epworth Hospital 
 Goulburn Valley Chronic Pain Service  
 Latrobe Regional Hospital 
 Melbourne Health Pain Management Service (The Royal Melbourne Hospital) 
 Monash Health Pain Management 
 Northern Health Pain Assessment and Management Service 
 Peninsula Health Chronic Pain Management Service 
 Precision Ascend Rehabilitation Centre 
 The Victorian Rehabilitation Centre 
 Western Health Pain Management 
 
Western Australia: 
 Fiona Stanley Hospital 
 PainCare 
 Sir Charles Gairdner Hospital 
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Appendix C — Relationship between levels of ePPOC 
data 
Five different levels of information are collected in epiCentre. These are: 
1. Patient (e.g. date of birth, country of birth) 
2. Episode – relating to the period of care at the pain service (e.g. referral date, comorbidities).  
A patient may have one or more episode of care at one pain service or at different pain services. 
3. Pathway – the type(s) of intervention provided to the patient. These can be group pain programs, 
individual appointments, one off interventions, or a combination of group pain and individual 
appointments occurring concurrently. A patient may follow one or more pathways during an episode 
of care at a pain service. 
4. Service event – the services provided to the patient during an episode of care. 
5. Questionnaire – including the patient reported outcome measures e.g. DASS21, BPI. 
 
Below is an example of how these levels of information are structured: 
 
  
Patient reported outcomes are collected at: 
 Referral – to record a baseline measure 
 Pathway starts and ends – to measure the effectiveness of interventions 
 Reviews (if a pathway lasts longer than 3 months) – to monitor change and 
improvement within an episode 
 After the episode ends (i.e. 3-6 months post episode) – to assess 
outcomes as a result of treatment at a service and whether improvements 
have been maintained. 
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Appendix D — Assessment tools 
The assessment tools used in ePPOC are: 
 Brief Pain Inventory (BPI) 
 Depression, Anxiety, Stress Scale (DASS) 
 Pain Catastrophising Scale (PCS) 
 Pain Self-Efficacy Questionnaire (PSEQ) 
 Global Rating of Change (GRC) 
 Work Productivity and Impairment (WPAI) 
 CARRA Body Chart. 
Each of these assessment tools are briefly described below. 
Brief Pain Inventory1 
The BPI items used in the ePPOC dataset measure the severity of pain and the degree to which the pain 
interferes with common activities of daily living. Pain severity questions are rated on a scale of 0 to 10,  
where 0 = ‘No pain’ and 10 = ‘Pain as bad as you can imagine’, with patients asked to rate their pain in four 
items including, average, worst and least pain over the last week, and their pain right now. Pain severity is 
then calculated as an average of these four items. Whereas the benchmark for average pain is based on the 
single average pain item only.  
Severity bands for these items are: 
 0-4 = mild pain 
 5-6 = moderate pain 
 7-10 = severe pain 
The IMMPACT group’s recommendations for assessing clinical significance for 0-10 numeric pain scales are 
that a change of:  
≥ 10% represents minimally important change 
≥ 30% represents moderate clinically important change (ePPOC uses this category to identify 
clinically significant improvement for average and worst pain) 
≥ 50% represents substantial clinically important change. 
The interference questions are rated on a scale of 0 to 10, where 0 = ‘Does not interfere’ and  
10 = ‘Completely interferes’. The interference subscale is an average of the seven interference questions.  
At least 4 of 7 questions must be completed for this subscale to be valid. The IMMPACT recommendation for 
assessment of clinically significant change on the BPI interference scale is a change of 1 point over the 
average of the 7 items2. 
  
                                                          
1 Modified Brief Pain Inventory, reproduced with acknowledgement of the Pain Research Group, University of Texas, MD Anderson 
Cancer Centre, USA 
2 Dworkin, RH, et al 2008, ‘Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT 
Recommendations.’ The Journal of Pain, vol. 9, no. 2, pp 105-121. 
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Depression Anxiety Stress Scales3 
The DASS measures the negative emotional states of depression, anxiety and stress. Due to the large number 
of questions in the full DASS (42 questions), the DASS21 is administered. This comprises 21 questions which 
are rated on a scale of 0 to 3, where 0 = ‘did not apply to me at all’, 1 = ‘applied to me to some degree, or 
some of the time’, 2 = ‘applied to me to a considerable degree, or a good part of the time’, or 3 = ‘applied to 
me very much, or most of the time’. Scores are multiplied by 2 to enable comparison with the full-scale 
DASS42 for which norms exist. 
For each subscale (Depression, Anxiety and Stress), the 7 items are summed and then multiplied by 2. The 
test developers suggest that at least 6 of 7 items should be complete for each subscale to be considered 
valid. Table 55 shows the range of scores associated with severity categories for each subscale. 
Table 54  DASS severity ratings 
 Depression Anxiety Stress 
Normal 0-9 0-7 0-14 
Mild 10-13 8-9 15-18 
Moderate 14-20 10-14 19-25 
Severe 21-27 15-19 26-33 
Extremely Severe 28+ 20+ 34+ 
 
Clinical significance on each of the DASS subscales requires a change of 5 or more points coupled with a 
move to a different severity category.  
Pain Catastrophising Scale4 
The PCS measures a patient’s thoughts and feelings related to their pain. This includes three subscales 
measuring the dimensions of Rumination, Magnification and Helplessness. The PCS comprises 13 questions 
(Rumination – 4 items, Magnification – 3 items, Helplessness – 6 items) which are rated on a scale of 0 to 4, 
where 0 = ‘not at all’, 1 = ‘to a slight degree’, 2 = ‘to a moderate degree’, 3 = ‘to a great degree’ and  
4 = ‘all the time’. For each subscale, all items must be completed to be valid. For the total to be valid, at least 
12 of 13 items must be completed. 
Severity bands for the PCS are: 
 <20 = mild 
 20 to 30 = high 
 >30 = severe. 
Clinically significant change requires a change in score of 6 or more points, combined with movement to a 
different severity category5.  
  
                                                          
3 Lovibond, SH and Lovibond, PF 1995, Manual for the Depression Anxiety Stress Scales, Psychology Foundation Monograph, Sydney, 
Australia. 
4 Sullivan, MJL, et al 1995, ‘The Pain Catastrophizing Scale: Development and Validation’, Psychological Assessment, vol. 7, num. 4, pp 
524-532. 
5 Sullivan, MJL, personal communication with Nicholas, MK July 2014. 
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Pain Self-Efficacy Questionnaire6 
The PSEQ measures how confident a patient is that he or she can do a range of activities despite their pain. 
The PSEQ Total is a sum of scores from 10 questions which are rated on a scale from 0 = ‘Not confident at all’ 
to 6 = ‘Completely confident’. At least 9 of 10 items must be complete for the PSEQ Total to be valid. 
Increases in score represent an improvement in self-efficacy.  
Severity bands for the PSEQ are: 
 <20 = severe 
 20 to 30 = moderate 
 31 to 40 = mild 
 >40 = minimal impairment. 
Clinically significant change requires a change in score of 7 or more points, combined with movement to a 
different severity category7.  
Global Rating of Change8 
The Global Rating of Change questions were included in Version 2 of the ePPOC dataset. They are asked in 
follow-up questionnaires only. The two questions are “Compared with before receiving treatment at this 
pain management service, how would you describe yourself now overall?” and “Compared with before 
receiving treatment at this pain management service, how would you describe your physical abilities now?” 
Participants answer by indicating their response on a Likert scale from -3 (very much worse) to +3 (very much 
better). This will provide an overview of how participants perceive their condition has changed overall as well 
as with respect to their physical functioning.  
Work Productivity and Impairment (WPAI)9 
WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater 
impairment and less productivity. The work status of all patients is collected using the International 
Consortium for Health Outcomes Measurement (ICHOM) categories. For patients who are employed,  
the WPAI items allow calculation of the following outcomes: 
 % of time missed from work due to pain (absenteeism) 
 % work impairment while working due to pain (lost productivity) 
 % overall work impairment due to pain (taking into account absenteeism and lost productivity). 
For more information on the calculations used please see the ePPOC Australian and New Zealand data 
dictionaries on the ePPOC website https://ahsri.uow.edu.au/eppoc/forms/index.html. 
 
  
                                                          
6 Nicholas, MK 1989, ‘Self-efficacy and chronic pain’, British Psychological Society, St. Andrews, Scotland. 
7 Nicholas, MK, personal communication, July 2014. 
8 Bartlett, A, Flett, P, Tardif, H and Hush, J 2017, Introducing a global measure of function and change in NSW pain services, 37th ASM 
of the Australian Pain Society, Adelaide, Australia. 
9 Reilly MC, Zbrozek AS, Dukes E 1993, ‘The validity and reproducibility of a work productivity and activity impairment measure’, 
PharmacoEconomics, vol. 4, num. 5, pp 353-365. 
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CARRA Body Chart10 
Patients identify the site/s they feel pain using body maps. For reporting, pain sites are categorised into pain 
areas as follows: 
 Pain sites 
Head head and face 
Neck neck 
Chest chest 
Back upper back, mid back and low back  
Leg left and right thighs, left and right calves, left and right ankles 
Arm/shoulder 
left and right shoulders, left and right upper arms, left and right elbows, 
left and right forearms, left and right wrists 
Abdomen abdomen 
Hands left and right hands 
Feet left and right feet 
Pelvic groin 
Knee left and right knees 
Hip left and right hips 
 
 
 
  
                                                          
10 Von Bayer CL, et al. 2011, ‘Pain charts (body maps or manikins) in assessment of location of paediatric pain’, Pain Management, 
vol. 1 num. 1, pp 61-68. (Source: Childhood Arthritis and Rheumatology Research Alliance, www.carragroup.org) 
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Appendix E — Interpreting benchmark graphs 
The ePPOC benchmarking graphs present results from your service in comparison to all other services 
participating in ePPOC.  In each graph, the shaded region describes the Australasian profile for that outcome 
measure.  The red line indicates the level at which the benchmark is previously set, and where applicable, the 
dashed blue line indicates the level at which the benchmark was previously set (benchmarks were revised for 
the 2018 Annual Report).  Your service is highlighted as a red dot. 
 
 
 The vertical axis shows the percentage of 
patients experiencing a clinically significant 
improvement 
 The purple region shows the Australasian 
profile for this benchmark. It contains all 
services that contributed to this 
benchmark, ordered from the highest to 
the lowest percentage 
 The dot indicates your position relative to 
the benchmark and the other contributing 
services. If there is no red dot on your 
graph this indicates that your service 
reported less than 10 outcomes for this 
benchmark 
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